SA PRO
Free Account
Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating
Buy
12 analysts·Moderate coverage
67%
Rating Distribution
Strong Buy
00%
Buy
867%
Hold
433%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 11, 2025Leerink Partners
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2 at Leerink Partners
Target:$2.00
+51.5%from $1.32
Jun 18, 2024Jefferies
Zentalis downgraded to Hold from Buy at Jefferies
Target:$6.00
+39.4%from $4.30
Jun 18, 2024Morgan Stanley
Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight
Target:$8.00
+93.2%from $4.14
Jun 18, 2024Stifel Nicolaus
Zentalis price target lowered to $10 from $32 at Stifel
Target:$10.00
+85.5%from $5.39
Jun 18, 2024Wedbush
Wedbush downgrades Zentalis to Underperform on unclear azeno path forward
Target:$4.00
-29.8%from $5.70
May 7, 2024Stifel Nicolaus
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $32 at Stifel
Target:$32.00
+157.4%from $12.43
Nov 14, 2022Wedbush
Wedbush Maintains Outperform on Zentalis Pharmaceuticals, Lowers Price Target to $32
Target:$32.00
+41.8%from $22.56
Nov 11, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Zentalis Pharmaceuticals, Lowers Price Target to $55
Target:$55.00
+163.2%from $20.90
Nov 11, 2022Guggenheim
Guggenheim Maintains Buy on Zentalis Pharmaceuticals, Lowers Price Target to $28
Target:$28.00
+31.1%from $21.35
Aug 10, 2022Leerink Partners
SVB Leerink Maintains Outperform on Zentalis Pharmaceuticals, Lowers Price Target to $42
Target:$42.00
+38.1%from $30.41
Aug 10, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on Zentalis Pharmaceuticals, Lowers Price Target to $55
Target:$55.00
+80.9%from $30.41
Jul 29, 2022Stifel Nicolaus
Zentalis loses top competitor with AstraZeneca discontinuation, says Stifel
Target:$70.00
+145.6%from $28.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance